Tibet Weixinkang Medicine Co Ltd Capital Reinvestment Ratio
Tibet Weixinkang Medicine Co Ltd capital reinvestment ratio. Tibet Weixinkang Medicine Co Ltd (603676) has a Capital Reinvestment Ratio of 1.36x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥13.68 Million) in capital expenditures (CN¥18.57 Million). See Tibet Weixinkang Medicine Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tibet Weixinkang Medicine Co Ltd (2013–2025)
Capital reinvestment ratio of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025. This chart tracks Tibet Weixinkang Medicine Co Ltd's Capital Reinvestment Ratio across 13 annual periods. See Tibet Weixinkang Medicine Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Tibet Weixinkang Medicine Co Ltd Capital Reinvestment Ratio by Year (2013–2025)
Tibet Weixinkang Medicine Co Ltd capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see 603676 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥185.53 Million | CN¥83.92 Million | ▲ +189.8% |
| 2024 | 0.16x | CN¥372.78 Million | CN¥58.18 Million | ▼ -43.4% |
| 2023 | 0.28x | CN¥256.67 Million | CN¥70.81 Million | ▼ -12.6% |
| 2022 | 0.32x | CN¥246.15 Million | CN¥77.69 Million | ▼ -3.1% |
| 2021 | 0.33x | CN¥170.69 Million | CN¥55.60 Million | ▼ -19.9% |
| 2020 | 0.41x | CN¥133.70 Million | CN¥54.35 Million | ▼ -1.0% |
| 2019 | 0.41x | CN¥106.34 Million | CN¥43.65 Million | ▼ -63.9% |
| 2018 | 1.14x | CN¥83.17 Million | CN¥94.50 Million | ▼ -7.5% |
| 2017 | 1.23x | CN¥63.30 Million | CN¥77.76 Million | ▲ +382.9% |
| 2016 | 0.25x | CN¥103.79 Million | CN¥26.40 Million | ▼ -32.7% |
| 2015 | 0.38x | CN¥114.47 Million | CN¥43.29 Million | ▼ -36.9% |
| 2014 | 0.60x | CN¥118.47 Million | CN¥70.97 Million | ▼ -45.4% |
| 2013 | 1.10x | CN¥88.59 Million | CN¥97.29 Million | — |